Cancer Survivorship Specialists in Boston, MAPage 5

Candace Haddox, M.D.

Clinical Investigator, Sarcoma Center

Oncology

John Sloan, M.D.

Associate Professor of Medicine, Boston University Chobanian & Avedisian School of Medicine; Program Director, Hematology/Oncology Fellowship; Member, Boston University-BMC Cancer Center; Member, Boston University Amyloidosis Center

Oncology

Mahasweta Gooptu, M.D.

Assistant Professor of Medicine, Harvard Medical School

Oncology

Andrew Aguirre, MD, PHD

Associate Professor of Medicine, Harvard Medical School

Oncology

Tara Berman, M.D.

Medical Oncologist, Dana-Farber Cancer Institute; Faculty Member, Harvard Medical School

Oncology

Zofia Piotrowska, MD

Associate Professor of Medicine, Harvard Medical School

Oncology

Myles Brown, M.D.

Chief of the Division of Molecular and Cellular Oncology at the Dana-Farber. In 2010 together with Shirley Liu he founded the Center for Functional Cancer; Director, Center for Functional Cancer Epigenetics

Oncology

Charlene Mantia, M.D.

Instructor in Medicine, Harvard Medical School

Oncology

Othon Iliopoulos, MD

Oncology

Martha Wadleigh, MD

Director, Inpatient Oncology; Assistant Professor of Medicine, Harvard Medical School

Oncology

Otto Metzger, M.D.

Director, International Strategic Initiatives; Assistant Professor of Medicine, Harvard Medical School

Oncology

Rochelle Scheib, MD

Professor of Medicine, Harvard Medical School

Oncology

Matthew Oser, M.D./PH.D.

Assistant Professor of Medicine at Dana-Farber Cancer Institute and Harvard Medical School where he runs a research laboratory focused on small cell lung cancer and is a; Associate Professor of Medicine, Harvard Medical School

Oncology

Rizwan Haq, MD, PHD

Assistant Professor, Harvard Medical School

Oncology

Shayna Sarosiek, MD

Senior Physician; Assistant Professor of Medicine, Harvard Medical School

Oncology

Franklin Huang, MD, PHD

Oncology

Ting Bao, M.D.

Director of the Zakim Center for Integrative Therapies and Healthy Living at the Dana-Farber Cancer Institute. She was a joint faculty member at Memoria

Oncology

Thomas Roberts, MD,MBA

Professor of Biological Chemistry and Molecular Pharmacology, Harvard Medical School

Oncology

David Jackman, M.D.

Director for Clinical Pathways and New Business Initiatives. His research interests include targeted therapies in lung cancer and mesothelioma, and canc; Senior Physician

Oncology

Laura Spring, M.D.

Assistant Professor of Medicine, Harvard Medical School

Oncology